Article
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome
29 Mar 2013
Abstract excerpt
Molecular biomarkers of cancer are needed to assist histologic staging in the selection of treatment, outcome risk stratification, and patient prognosis. This is particularly important for patients with early-stage disease. We show that shedding of the extracellular domain of activated leukocyte cell adhesion molecule (ALCAM) is prognostic for outcome in patients with colorectal cancer (CRC). Previous reports on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
